COMMUNIQUÉS West-GlobeNewswire

Inventiva obtient le statut « Fast Track » de la FDA pour son produit candidat phare, lanifibranor, dans la NASH
26/09/2019
Ce statut est destiné à faciliter le développement et à accélérer l’examen réglementaire de lanifibranor pour le traitement de la NASH Daix (France), le 26 septembre 2019 – Inventiva (Euronext : IVA), société [...]
Genmab Announces U.S. FDA Approval of DARZALEX® (daratumumab) in Combination with Bortezomib, Thalidomide and Dexamethasone for Frontline Multiple Myeloma
26/09/2019
Company Announcement DARZALEX (daratumumab) approved by U.S. FDA in combination with bortezomib, thalidomide (an immunomodulatory agent) and dexamethasone as treatment for patients newly diagnosed with multiple myeloma [...]
Disclosure of a transparency notification
26/09/2019
PRESS RELEASE : REGULATED INFORMATION 26 September 2019, 17:40 CEST Disclosure of a transparency notification Mechelen, Belgium, 26 September 2019 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative [...]
Clinical Validations for IV-Cell™ and HemeScreen™ Completed
26/09/2019
Orders expected from several major labs both domestically and internationally NEW HAVEN, Conn., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced that as it [...]
Theratechnologies Included in the First TSX30 Ranking
26/09/2019
MONTREAL, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that it ranked 21 st on the first TSX30 ranking of top performers on the Toronto Stock Exchange. [...]
Theratechnologies se classe au palmarès TSX30
26/09/2019
MONTRÉAL, 26 sept. 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer qu’elle occupe la 21 e position du tout premier classement TSX30 des sociétés les plus [...]
Vaxart Announces Pricing of $8 Million Underwritten Public Offering
26/09/2019
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biopharmaceutical company focused on the development of oral recombinant vaccines based on its proprietary [...]
Pressure BioSciences’ PCT Platform Featured in Multiple Presentations at Major International Science Conference
26/09/2019
Ten Presentations by Scientists from Seventeen Research Institutions Worldwide Highlight Novel Applications for PBI’s PCT Platform in Cancer Research and Diagnostics South Easton, MA, Sept. 26, 2019 (GLOBE NEWSWIRE) -- [...]
Emergent BioSolutions to Participate in Cantor Fitzgerald Global Healthcare Conference
26/09/2019
GAITHERSBURG, Md., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the Cantor Fitzgerald Global [...]
BAHAMAS: PROJECT HOPE PROVIDES URGENTLY NEEDED MEDICAL CARE TO HURRICANE DORIAN SURVIVORS
26/09/2019
Global health organization plans waves of medical teams through November Millwood, Virginia, Sept. 26, 2019 (GLOBE NEWSWIRE) -- The global health and humanitarian relief organization Project HOPE has deployed a medical [...]
CareDx Files Patent Infringement Lawsuit Against Eurofins Viracor
26/09/2019
CareDx protects transplantation innovation by enforcing patent protection BRISBANE, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, [...]
NeuBase Therapeutics to Present at the Chardan 3rd Annual Genetic Medicines Conference
26/09/2019
PITTSBURGH, Sept. 26, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ: NBSE) (“NeuBase” or the “Company”), a biotechnology company developing next-generation antisense therapies to address genetic diseases, [...]
MannKind Corporation to Present at the 2019 Cantor Global Healthcare Conference
26/09/2019
WESTLAKE VILLAGE, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases [...]
The Silverstein Foundation and Q-State Biosciences Launch Chamishi Therapeutics
26/09/2019
NEW YORK and CAMBRIDGE, Mass., Sept. 26, 2019 (GLOBE NEWSWIRE) -- The Silverstein Foundation for Parkinson’s with GBA and Q-State Biosciences today announced the formation and launch of Chamishi Therapeutics, a drug [...]
Adamis Pharmaceuticals Announces Presentation Pertaining to Its High Dose Naloxone Product Candidate at IHV Scientific Meeting
26/09/2019
SAN DIEGO, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today that Dr. Ronald Moss, Chief Medical Officer, will be presenting data on October 4, 2019, pertaining to the [...]
Zosano Pharma to Present at the Cantor Global Healthcare Conference
26/09/2019
FREMONT, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its chairman, president and chief executive officer, John [...]
Helsinn demonstrates commitment to MF CTCL with multiple scientific sessions at the EORTC Cutaneous Lymphoma Meeting 2019
26/09/2019
Helsinn demonstrates commitment to MF CTCL with multiple scientific sessions at the EORTC Cutaneous Lymphoma Meeting 2019 Lugano, Switzerland, September 26, 2019 – Helsinn, the Swiss pharmaceutical group focused on [...]
Achillion to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
26/09/2019
BLUE BELL, Pa., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and families affected by [...]
Mustang Bio to Participate in October 2019 Investor Conferences
26/09/2019
NEW YORK, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]

Pages